← All Neogenomics INC filings

Neogenomics INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
NEO
Neogenomics INC
10-K: NeoGenomics Reports Increased Revenue and Improved Profitability in 2024 Annual Filing
NeoGenomics' 2024 annual report highlights a revenue increase of 11.6% and significant improvements in profitability.
NASDAQ
NEO
Neogenomics INC
10-K: NeoGenomics Reports 16% Revenue Increase in 2023, Driven by Clinical Services Growth
NeoGenomics, Inc. saw a 16% increase in consolidated revenue in 2023, primarily driven by an 18.4% growth in its Clinical Services segment.